Summary
The plasma drug concentration-effect relationship after an oral dose of 100 mg metoprolol has been studied in 8 women in the third trimester of a pregnancy complicated by hypertension. The study was repeated 3–5 months after parturition when all but 2 women were normotensive. Systolic and diastolic blood pressures (SBP and DBP) were measured in the sitting position followed by the change in heart rate on exercise. The average peak plasma concentration of metoprolol was almost 4-times higher in the non-pregnant state. Despite this difference, the reduction in exercise tachycardia and resting SBP was only slightly more pronounced after delivery than during pregnancy. In relation to the plasma drug concentration, metoprolol had four-times and twice the effect on heart rate and SBP during pregnancy as compared to the post partum period. The altered chronotropic response to metoprolol during pregnancy may be due to increased sensitivity or altered function of the β-adrenergic system.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Borg KO, Carlsson E, Hoffmann K-J, Jönsson T-E, Thorin H, Wallin B (1975) Metabolism of metoprolol-(3H) in man, the dog and the rat. Acta Pharmacol Toxicol 36 [Suppl 5]: 125–135
Dam M, Christiansen J, Munch O, Mygind KI (1977) Antiepileptic drugs: metabolism in pregnancy. Clin Pharmacokinet 4: 53–62
Ervik M (1975) Quantitative determination of metoprolol in plasma and urine by gas chromatography. Acta Pharmacol Toxicol 36 [Suppl 5]: 134–144
Gallery EDM, Saunders DM, Hunyor SN, Gyory AZ (1979) Randomized comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. BMJ I: 1591–1594
Gugler R, Christ R, Raczinski H, Höffgen K, Bodem G (1979) Pharmacokinetic and pharmacodynamic comparison of three beta-adrenoceptor blocking drugs. Naunyn Schmiedebergs Arch Pharmacol 307: R76 (303)
Högstedt S, Lindberg B, Rane A (1983) Increased oral clearance of metoprolol in pregnancy. Eur J Clin Pharmacol 24: 217–220
Högstedt S, Lindberg B, Peng DR, Reg»rdh C-G, Rane A (1985) Pregnancy-induced increase in metoprolol metabolism. Clin Pharmacol Ther 37: 688–692
Högstedt S, Lindeberg S, Axelsson O, Lindmark G, Rane A, Sandström B, Lindberg BS (1985) A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy. Acta Obstet Gynecol Scand 64: 505–510
Högstedt S, Lindberg B, Reg»rdh C-G, Moström U, Rane A (1990) The Rhesus monkey as a model for studies of pregnancy-induced changes in metoprolol metabolism. Pharmacol Toxicol 66: 32–36
Hytten FE, Leitch I (1971) The physiology of human pregnancy. 2nd edition. Oxford: Blackwell Scientific Publications
Johnsson G, Reg»rdh C-G, Sölvell L (1975) Combined pharmacokinetic and pharmacodynamic studies in man of the adrenergic-receptor antagonist metoprolol. Acta Pharmacol Toxicol 36 [Suppl 5]: 31–44
Kjellmer I, Dagbjartsson A, Hrbek K, Karlsson K, Rosén KG (1984) Maternal beta-adrenoreceptor blockade reduces fetal tolerance to asphyxia. A study in pregnant sheep. Acta Obstet Gynecol Scand [Suppl 118]: 75–80
Krauer B, Krauer F (1977) Drug kinetics in pregnancy. Clin Pharmacokinet 2: 1671–1681
Lander CM, Edwards WE, Eadie MJ, Tyrer JH (1977) Plasma anticonvulsant concentrations during pregnancy. Neurology 27: 128–131
Lyrenäs S, Grahnén A, Lindberg B, Lindström B, Lönnerholm G (1986) Pharmacokinetics of terbutaline during pregnancy. Eur J Clin Pharmacol 29: 619–623
Nau H, Kuhnz W, Egger H-J, Rating D, Helge H (1982) Anticonvulsants during pregnancy and lactation: Transplacental maternal and neonatal pharmacokinetics. Clin Pharmacokinet 7: 508–543
O'Hare MF, Leahey W, Murnaghan GA, McDevitt DG (1983) Pharmacokinetics of sotalol during pregnancy. Eur J Clin Pharmacol 24: 521–524
Philipsson A (1977) Pharmacokinetics of ampicillin during pregnancy. J Infect Dis 136: 370–376
Rane A, Högstedt S, Lindberg B, Reg»rdh C-G, Jorulf H (1984) Comparison of different clearance estimates for metoprolol in the Rhesus monkey. J Pharmacol Exp Ther 228: 774–778
Reg»rdh C-G, Johnsson G, Jordö L, Sölvell L (1975) Comparative bioavailability and effect studies in metoprolol administered as ordinary and slow-release tablets in single and multiple doses. Acta Pharmacol Toxicol 36 [Suppl 5]: 45–58
Robinson BF, Epstein SE, Beiser GD, Braunwald E (1966) Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise. Circ Res 21: 400–411
Rubin PC, Butters L, Kelman AW, Fitzsimons C, Reid JL (1983) Labetalol disposition and concentration-effect relationship during pregnancy. Br J Clin Pharmacol 15: 465–470
Wichman K, Karlberg BE, Rydén G (1985) Metoprolol in the treatment of mild to moderate hypertension in pregnancy — effects on the mother. Clin Exper Hypertens Preg B4 (2&3): 141–156
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Högstedt, S., Rane, A. Plasma concentration — effect relationship of metoprolol during and after pregnancy. Eur J Clin Pharmacol 44, 243–246 (1993). https://doi.org/10.1007/BF00271365
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00271365